Welcome to our dedicated page for Milestone Scientific news (Ticker: MLSS), a resource for investors and traders seeking the latest updates and insights on Milestone Scientific stock.
Milestone Scientific, Inc. (NASDAQ: MLSS) is a pioneering company in the field of medical and dental anesthesia. The company focuses on the development, manufacture, marketing, and sale of computer-controlled local anesthetic delivery (C-CLAD) systems designed to provide improved and painless local anesthetic delivery. These systems are marketed under various trademarks for different applications. For dentistry, the products are known as CompuDent™ and STA™ (Single Tooth Anesthesia) System. These innovative devices allow for painless injections during a wide range of dental procedures, from routine cleanings to complex surgeries involving implants, root canals, and crowns.
For medical applications, Milestone Scientific offers similar technology under the CompuMed™ trademark. Their products are used across various medical disciplines, including plastic surgery, hair restoration surgery, podiatry, colorectal surgery, dermatology, and orthopedics. The company's advanced anesthetic delivery systems are sold both in the United States and in over 25 countries worldwide, highlighting their global reach and impact.
Besides their core product offerings, Milestone Scientific also provides The Wand™, a handpiece that allows for almost painless injections, enhancing patient comfort significantly.
The firm's operations are divided into two main segments: Dental and Medical. Geographically, all operations are concentrated in the United States, but their products are influential on a global scale.
Recent Achievements:
- Successful evaluations by prominent medical professionals, such as Dr. Matthew Stottle of Omaha Pain Physicians, achieving 100% success rates.
- Acceleration in reimbursement claims submission for the CompuFlo® Epidural System.
For more information or inquiries, Milestone Scientific can be contacted through Crescendo Communications, LLC via email at mlss@crescendo-ir.com or by phone at 212-671-1020.
Milestone Scientific Inc. (NYSE: MLSS) announced a conference call for 8:30 AM ET on November 17, 2020, to discuss its third-quarter financial results for the period ending September 30, 2020. The call will address the company's corporate progress and developments. Interested parties can access the call via the company's website or by dialing specific numbers for U.S. and international callers. Milestone Scientific is known for its innovative computerized drug delivery instruments aimed at providing painless injections.
Milestone Scientific (MLSS) has published a video interview featuring Dr. Ayman A. Alian from Yale School of Medicine. The interview showcases the CompuFlo® Epidural System and CathCheck™, highlighting their benefits in improving epidural procedures. Dr. Alian emphasizes that these technologies enhance block efficiency, reduce complications, and improve patient satisfaction. CEO Arjan Haverhals expresses gratitude for Dr. Alian's support, reinforcing the technology's potential to become the standard in care.
Milestone Scientific (MLSS) announced a group purchasing agreement with Premier, effective November 1, 2020. This deal grants Premier’s network of approximately 4,100 hospitals and 200,000 providers preferred access to the CompuFlo® Epidural System and CathCheck™. The agreement aims to enhance healthcare delivery by offering special pricing and terms, reducing complication rates and hospital stay costs. This collaboration is expected to accelerate Milestone's commercialization efforts and improve health outcomes during the ongoing COVID-19 pandemic.
Milestone Scientific Inc. (NYSE American:MLSS) announced an investor webinar on September 14, 2020, at 4:00 p.m. ET, led by Interim CEO Leonard Osser. The session aims to discuss recent company developments and future milestones, followed by a live Q&A. Milestone is known for its innovative computerized drug delivery instruments, focusing on painless injections using its proprietary DPS Dynamic Pressure Sensing technology. Participants can register for the webinar online and pre-submit questions. The company emphasizes the forward-looking nature of its statements, which carry inherent risks and uncertainties.
Milestone Scientific (MLSS) anticipates a substantial increase in Q3 2020 dental revenues, projecting at least a four-fold rise compared to Q2 2020. The company's Wand® dental business is beginning to recover as dental offices reopen, aided by promotions to boost sales of disposables and instruments. Additionally, there is growth in active trials of the CompuFlo® Epidural System, with new partnerships and a strategy to shorten the sales cycle by lending instruments to hospitals. Overall, there is a robust sales pipeline and positive feedback from both domestic and international markets.
Milestone Scientific (MLSS) has announced the promotion of Jan Adriaan Haverhals to President, effective immediately. Haverhals, who joined the company in June 2020 as President and CEO of Wand Dental, brings over 30 years of experience in sales and marketing within the medical device sector. His leadership is expected to accelerate the commercialization of Milestone's CompuFlo® Epidural Instrument and CathCheck™ technologies in the U.S. and Europe. Leonard Osser, Interim CEO, expressed confidence in Haverhals' abilities to enhance sales and marketing efforts and foster collaborations with major health systems.
Milestone Scientific (NYSE American: MLSS) announced its participation in the LD 500 virtual investor conference from September 1-4, 2020. Interim CEO Len Osser will present on September 1 at 2:40 p.m. ET. The presentation will be available via a live webcast on the conference platform. One-on-one meetings can be requested online or via email. The LD 500 event will showcase key players in the small and micro-cap sector, featuring interviews and keynote speeches. For more details on Milestone Scientific's technology and services, visit their website.
Milestone Scientific (NYSE:MLSS) reported Q2 2020 revenues of approximately $167,000, down from $2.2 million in Q2 2019, significantly impacted by the COVID-19 pandemic. The operating loss for the quarter increased to approximately $(3.1) million, compared to $(1.1) million in the prior year. For the first six months, revenues dropped to $1.9 million from $4.1 million in H1 2019. Despite the downturn, the company ended the quarter with over $16.6 million in cash, allowing it to enhance sales activities and adapt to market conditions. The focus remains on the commercialization of the CompuFlo Epidural System.
Milestone Scientific Inc. (MLSS) announced a conference call on August 17, 2020, at 8:30 AM ET, to discuss its financial results for Q2 2020 ending June 30. The call aims to cover corporate progress and developments. Investors can participate via the company's website or by telephone. A replay will be available within an hour after the call until August 31, 2020. Milestone Scientific focuses on innovative drug delivery instruments that enhance injection precision and comfort, utilizing its proprietary Dynamic Pressure Sensing technology.
Milestone Scientific (NYSE American: MLSS) has announced a conference call scheduled for August 17, 2020, at 8:30 AM ET to discuss its financial results for Q2 2020 and corporate developments. Interested parties can access the call via the company's website or by dialing the appropriate toll-free numbers. The call will also be archived for later access. Milestone specializes in innovative injection technologies aimed at providing painless and precise injections, utilizing their proprietary DPS Dynamic Pressure Sensing technology.
FAQ
What is the current stock price of Milestone Scientific (MLSS)?
What is the market cap of Milestone Scientific (MLSS)?
What does Milestone Scientific, Inc. do?
What are the main products offered by Milestone Scientific?
Where are Milestone Scientific’s products sold?
What recent achievements has Milestone Scientific accomplished?
What are the main segments of Milestone Scientific’s business?
How can Milestone Scientific be contacted?
What is The Wand™?
What is the STA™ System?
Which medical disciplines use Milestone Scientific’s systems?
What is CompuMed™?
